BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21825099)

  • 1. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
    Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
    de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
    Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
    Diaz EM; Johnigan RH; Pero C; El-Naggar AK; Roberts DB; Barker JL; DeMonte F
    Head Neck; 2005 Feb; 27(2):138-49. PubMed ID: 15654688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 34 cases of esthesioneuroblastoma].
    Liu WS; Tang PZ; Xu GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 20 adults esthesioneuroblastoma with combined therapy].
    Li JS; Xie FY; Peng M; Han F
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):36-9. PubMed ID: 19484986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors and outcome of esthesioneuroblastoma].
    Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
    Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
    J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality therapy of esthesioneuroblastoma.
    McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
    Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
    Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory neuroblastoma: a case report and review of the literature.
    Ghaffar S; Salahuddin I
    Ear Nose Throat J; 2005 Mar; 84(3):150-2. PubMed ID: 15871582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival.
    Kim JW; Kong IG; Lee CH; Kim DY; Rhee CS; Min YG; Kim CW; Chung JH
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):708-12. PubMed ID: 18984268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.
    Jethanamest D; Morris LG; Sikora AG; Kutler DI
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):276-80. PubMed ID: 17372086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
    El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
    Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
    Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory neuroblastoma: past, present, and future?
    Lund VJ; Howard D; Wei W; Spittle M
    Laryngoscope; 2003 Mar; 113(3):502-7. PubMed ID: 12616204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.